News
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing with U.S. FDA for EUA
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases...
Drug Research
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the UK government for an additional 2 million doses of mRNA-1273,...
News
Wasdell Group strengthens PPFL business with ISO 13485 for medical devices
The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has announced that its Dundalk, Ireland facility has been certified to comply with the ISO 13485 standard for medical device manufacturing.
The ISO 13485 is...
News
Saudi Pharma in talks with Germanys CureVac for coronavirus shot
Saudi Pharmaceutical Industries and Medical Appliances Corp. have signed a non-binding memorandum of understanding with German biotech company CureVac NV to provide a Covid-19 vaccine in Saudi Arabia.
Shares in the two companies surged to the highest level in more...
News
Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
Recipharm, a leading contract development and manufacturing organisation (CDMO) announces that it has signed a letter of intent with Moderna, a U.S. based biotech company, to formulate, fill and finish mRNA-1273, Moderna’s COVID-19 vaccine candidate. The activity will be...
News
Patent Protection Lift-off For COVID-19 Vaccines; Not a Bright Choice
The world of Pharmaceuticals is caught in the web of who brings out the vaccine and when scenario. The darkest hours that the world has been a witness to are from the last 10 months. However, every day, there...
News
Idifarma partners with industry expert to strengthen spray drying expertise
SPANISH contract development and manufacturing organisation (CDMO) Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento SA.
Bringing with him the benefit of over 25 years of experience in the pharmaceutical and fine chemical industry,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















